Richard Dilorio
Vorstandsvorsitzender bei INFUSYSTEM HOLDINGS, INC.
Vermögen: 3 Mio $ am 31.05.2024
Profil
Mr. Richard A.
Dilorio is an Independent Director at Dignitana AB and a Chief Executive Officer & Director at InfuSystem Holdings, Inc. He is on the Board of Directors at Dignitana AB and InfuSystem Holdings, Inc. Mr. Dilorio was previously employed as an Executive Vice President-Oncology Sales by InfuSystem, Inc. He received his undergraduate degree from Boston College.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
18.05.2024 | 440 121 ( 2,07% ) | 3 Mio $ | 31.05.2024 |
Aktive Positionen von Richard Dilorio
Unternehmen | Position | Beginn |
---|---|---|
INFUSYSTEM HOLDINGS, INC. | Vorstandsvorsitzender | 15.11.2017 |
DIGNITANA AB | Direktor/Vorstandsmitglied | 01.01.2020 |
Ehemalige bekannte Positionen von Richard Dilorio
Unternehmen | Position | Ende |
---|---|---|
InfuSystem, Inc.
InfuSystem, Inc. Medical SpecialtiesHealth Technology Part of InfuSystem Holdings, Inc., InfuSystem, Inc. is a company that manufactures external ambulatory infusion pumps. The company is based in Madison Heights, MI. InfuSystem was acquired by HAPC, Inc. from I-Flow Corp. on October 26, 2007 for $112 million. | Corporate Officer/Principal | 01.11.2016 |
Ausbildung von Richard Dilorio
Boston College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
INFUSYSTEM HOLDINGS, INC. | Commercial Services |
DIGNITANA AB | Health Technology |
Private Unternehmen | 1 |
---|---|
InfuSystem, Inc.
InfuSystem, Inc. Medical SpecialtiesHealth Technology Part of InfuSystem Holdings, Inc., InfuSystem, Inc. is a company that manufactures external ambulatory infusion pumps. The company is based in Madison Heights, MI. InfuSystem was acquired by HAPC, Inc. from I-Flow Corp. on October 26, 2007 for $112 million. | Health Technology |